|

Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma

RECRUITINGSponsored by H. Lee Moffitt Cancer Center and Research Institute
Actively Recruiting
SponsorH. Lee Moffitt Cancer Center and Research Institute
Started2025-07-17
Est. completion2028-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07030400

Summary

The study aims to improve our understanding of how quality of life, fatigue, and symptoms change over 2 years when participants are treated for chronic lymphocytic leukemia or small lymphocytic lymphoma. We will compare two types of treatment to help future patients with chronic lymphocytic leukemia or small lymphocytic lymphoma know what to anticipate.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All patients with pathology-confirmed diagnoses of CLL who are within seven days of starting treatment with a BTKi +/- an anti-CD 20 monoclonal antibody or BCL2i with Obinutuzumab treatment will be included.
* Subjects must be able to read and speak English or Spanish at the 8th grade level.

Exclusion Criteria:

* Patients with dementia, traumatic brain injury, or individuals with central nervous system involvement of their leukemia will be excluded from study participation.

Conditions3

CancerChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)

Locations1 site

Moffitt Cancer Center
Tampa, Florida, 33612
Sara Tinsley-Vance, PhD, APRN, AOCN

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.